American Pharmacy News
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • Home
  • »
  • Stories
  • »
  • 2020
  • »
  • February

Mako Medical Caps Pharmacy Cost for Over 300 Medications

Press release submission | Feb 7, 2020

MakoRx's new disruptive pharmacy subscription model provides access to over 300 medications for free Read More »

Save on Prescriptions with ValpakRx

American Pharmacy News Reports | Feb 7, 2020

As healthcare costs continue to rise in 2020, Valpak, a leader in local print and digital marketing, recently announced a new way to help their customers save on prescription drugs: ValpakRx. Read More »

RXSENSE: Joins Health Plan Alliance Group Purchasing Organization

American Pharmacy News Reports | Feb 12, 2020

Healthcare Technology Company Becomes Organization’s Provider of Enterprise Solutions for Pharmacy Benefits Administration Read More »

PTCE: Pharmacy Times Continuing Education™ to Present Three Educational Symposia at the Hematology/Oncology Pharmacy Association 16th Annual Conference

Press release submission | Feb 16, 2020

The educational sessions are available live and via simulcast Read More »

AVION PHARMACEUTICALS: New gout prophylaxis product, GLOPERBA®, is the first and only liquid form of colchicine (1,2)

American Pharmacy News Reports | Feb 27, 2020

FDA-approved GLOPERBA (colchicine) is now available in pharmacies Read More »

APHA: Urges Regulators to Revise Their Review Process of Healthcare Vertical Mergers

American Pharmacy News Reports | Feb 28, 2020

The American Pharmacists Association (APhA) submitted comments to the Federal Trade Commission (FTC) and the U.S. Department of Justice (DOJ) Antitrust Division addressing the impact vertical mergers are having on the pharmacy supply chain, medication pricing and patient access and choice. Read More »

Trending

Diana Harshbarger, U.S. Representative for Tennessee's 1st District

Rep. Harshbarger calls for PBM transparency, oversight: 'It’s time to shine a light on their shady practices'

Ted Okon, MBA, Executive Director, Community Oncology Alliance

Community Oncology Alliance Executive Director Okon on 340B: ‘Expanding participation in a flawed program isn’t reform’

Elise Shutzer, Vice President of Public Affairs at PhRMA

PhRMA launches 'Goldmine: Spa Day' campaign targeting 340B hospital drug pricing program

Paul Gigot, Editor-in-chief, Wall Street Journal

WSJ Editorial Board says 340B program has been exploited following North Dakota ruling

Sally Pipes, President & CEO of Pacific Research Institute

Pacific Research Institute CEO Pipes on 340B program: It 'has become a major revenue stream for large hospital systems'

Copyright © 2026 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up